Association of Lipoprotein(a) With Atrial Fibrillation in the Framingham Heart Study

Celestin Hategeka; Emelia Benjamin; Sarah R. Preis

doi:10.1016/j.jacadv.2025.102343

Related publications

Article2017

Methylome-wide Association Study of Atrial Fibrillation in Framingham Heart Study

Honghuang Lin, Xiaoyan Yin, Zhijun Xie, Kathryn L. Lunetta, Steven A. Lubitz, Martin G. Larson, Darae Ko, Jared W. Magnani, Michael Mendelson, Chunyu Liu, David D. McManus, Daniel Levy, Patrick T. Ellinor, Emelia Benjamin

Article2022

The association between eicosanoids and incident atrial fibrillation in the Framingham Heart Study

Jelena Kornej, Maha A. Qadan, Mona Alotaibi, David R. Van Wagoner, Jeramie D. Watrous, Ludovic Trinquart, Sarah R. Preis, Darae Ko, Mohit Jain, Emelia Benjamin, Susan Cheng, Honghuang Lin

Article2024

The association of exhaled carbon monoxide with atrial fibrillation and left atrial size in the Framingham Heart Study

Oseiwe Eromosele, Ayelet Shapira‐Daniels, Amy Yuan, Abdulkareem Lukan, Olumuyiwa Akinrimisi, Marius Chukwurah, Matthew Nayor, Emelia Benjamin, Honghuang Lin

Article2025

ASSOCIATION OF LIFE’S ESSENTIAL 8 SCORE WITH INCIDENCE OF ATRIAL FIBRILLATION: A FRAMINGHAM HEART STUDY

Camilo Toro, Ayelet Shapira‐Daniels, Vanessa Xanthakis, Brenton Prescott, Matthew Nayor, Emelia Benjamin, Sarah R. Preis

Article2025

Association of life’s essential 8 score with incidence of atrial fibrillation: The Framingham heart study

Camilo Toro, A. Daniels, Brenton Prescott, Vanessa Xanthakis, Matthew Nayor, Priya Gajjar, Emelia Benjamin, Sarah R. Preis